Cancer Pain: Part 2: Physical, Interventional and Complimentary Therapies; Management in the Community; Acute, Treatment-Related and Complex Cancer Pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners

Pain Medicine

Volumn 11, Issue 6, 2010, Pages 872-896

  Raphael, Jon ^a   Hester, Joan ^b   Ahmedzai, Sam ^h   Barrie, Janette ⁱ   Farqhuar Smith, Paul ^c   Williams, John ^c   Urch, Catherine ^d   Bennett, Michael I ^j   Robb, Karen ^e   Simpson, Brian ^k   Pittler, Max ^q   Wider, Barbara ^l   Ewer Smith, Charlie ^m   DeCourcy, James ^p   Young, Ann ^p   Liossi, Christina ⁿ   McCullough, Renee ^f   Rajapakse, Dilini ^f   Johnson, Martin ^g   Duarte, Rui ^a   Sparkes, Elizabeth ^o   more..

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^g ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ Lanarkshire Health   (United Kingdom)

^j LANCASTER UNIVERSITY   (United Kingdom)

^k UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^l PENINSULA MEDICAL SCHOOL   (United Kingdom)

^m UNIVERSITY OF BRISTOL   (United Kingdom)

ⁿ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^o Institute for Clean Growth and Future Mobility   (United Kingdom)

^p GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^q INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

more..

Author keywords

Cancer Pain; Palliative Treatment

Indexed keywords

ACETYLCARNITINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIFOSTINE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BORTEZOMIB; CARBOPLATIN; CISPLATIN; DOCETAXEL; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; HYDROMORPHONE; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIPLATIN; OXYCODONE; PACLITAXEL; PETHIDINE; SODIUM CHANNEL BLOCKING AGENT; THALIDOMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ANALGESIC AGENT;

ACUPUNCTURE ANALGESIA; AGE DISTRIBUTION; ALTERNATIVE MEDICINE; AROMATHERAPY; ARTICLE; BRACHIAL PLEXUS NEUROPATHY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CAREGIVER; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CHRONIC PAIN; COGNITIVE THERAPY; CONSENSUS DEVELOPMENT; CORDOTOMY; CRYOTHERAPY; DEMENTIA; DRUG MEGADOSE; FAMILY; GENERAL PRACTITIONER; HEAD AND NECK SURGERY; HEALTH CARE ACCESS; HERBAL MEDICINE; HOME CARE; HOMEOPATHY; HUMAN; HYPERTHERMIC THERAPY; HYPNOSIS; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MAINTENANCE THERAPY; MASSAGE; MEDICAL PROFESSION; MEDICAL SOCIETY; MENTAL STRESS; MUCOSA INFLAMMATION; MUSIC THERAPY; NERVE BLOCK; NEUROPHYSIOLOGY; OCCUPATIONAL THERAPY; OCCUPATIONAL THERAPY ASSESSMENT; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SAFETY; PATIENT SELECTION; PELVIS PAIN SYNDROME; PERCUTANEOUS VERTEBROPLASTY; PERIPHERAL NEUROPATHY; PHYSIOTHERAPY; POSTOPERATIVE PAIN; PREVALENCE; RADIATION INJURY; REFLEXOLOGY; RELAXATION TRAINING; SURGICAL TECHNIQUE; THORACOTOMY; TRANSCUTANEOUS NERVE STIMULATION; UNITED KINGDOM; ADOLESCENT; ADULT; ANALGESIA; CHILD; COMPLICATION; MULTIMODALITY CANCER THERAPY; NEOPLASMS; ORGANIZATION; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANALGESICS; CAREGIVERS; CHILD; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; GREAT BRITAIN; HUMANS; NEOPLASMS; PAIN; PALLIATIVE CARE; PHYSICIANS, FAMILY; SOCIETIES; TREATMENT OUTCOME; PAIN MANAGEMENT;

EID: 77954437456     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00841.x     Document Type: Article

References (161)

1. Gysels M, Higgenson IL. Improving Supportive and Palliative Care for Adults with Cancer: NICE Guidance on Cancer Services. 2004, http://nice.org.uk, Available at: (accessed March 25, 2010
2. Describing Pain [online]. 2005, http://cancerbackup.org.uk/resourcessupport/symptomssideeffects/pain, Cancerbackup, Available at: (accessed November 2006
3. Gamlin R, Lovel T. Pain Explained: A Guide for Patients and Carers 2002, Rugby, Altman Publishing
4. Lin CC, Lai YL, Ward SE. Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. J Pain Symptom Manag 2003, 25(1):29-37.
5. Turk DC, Sist TC, Okifuji A. Adaptation to metastatic cancer pain, regional/local cancer pain and non-cancer pain: Role of psychological and behavioural factors. Pain 1998, 74(2-3):247-56.
6. Ferrell BR, Grant M, Borneman T, Juarez G, ter-Veer A. Family care giving in cancer pain management. J Palliat Med 1999, 2(2):185-95.
7. Bates MS, Edwards WT, Anderson KO. Ethnocultural influences on variation in chronic pain perception. Pain 1993, 52:101-12.
8. Breitbart W, Payne D, Passik SD. Psychological factors in pain experience. Oxford Textbook of Palliative Medicine 2004, 425-6. Doyle D, Hanks G, Cherny NCalman K. eds., 3rd, edition, Oxford, Oxford Press
9. Strong J, Sturgess J, Unruh AM, Vicenzino B. Pain assessment and measurement. Pain. A Textbook for Therapists 2002, 123-47. Strong J, Unruh A, Wright A, Baxter G. eds., Edinburgh, Churchill Livingstone
10. Simmonds M. Physical function and physical performance in patients with pain: What are the measures and what do they mean? Pain 1999 An Updated Review. Refresher Course Syllabus 1999, 127-36. Max M. ed., Seattle, WA, IASP press
11. Serlin C, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995, 61:277-84.
12. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singap 1994, 23(2):129-38.
13. Baptiste S, Law M, Pollock N. The Canadian occupational performance measure. WFOT Bull 1993, 28:47-51.
14. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975, 1:277-99.
15. Douglas E. Exercise in cancer patients. Phys Ther Rev 2005, 10(22):71-88.
16. Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer patients: A systematic review of controlled trials. Cancer Cause Control 2004, 15(10):1035-56.
17. Kennett CE. Participation in a creative arts project can foster hope in a hospice day centre. Palliative Med 2000, 14(5):419-25.
18. Heck SA. The effect of purposeful activity on pain tolerance. Am J Occup Ther 1987, 42(9):577-81.
19. Macrae WE. Chronic pain after surgery. Br J Anaesth 2001, 87(1):88-98.
20. McNeely ML, Parliament M, Courneya CS. A pilot study of a randomised controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck 2004, 26(6):518-30.
21. Hunter G. Specific soft tissue mobilization in the treatment of soft tissue lesions. Physiotherapy 1994, 80:15-21.
22. Mannheim CJ. The Myofascial Release Manual 2001, 3rd, edition, New Jersey, Slack Incorporated
23. Robb K, Newham D, Williams JE. Transcutaneous electrical nerve stimulation vs transcutaneous spinal electroanalagesia for chronic pain associated with breast cancer treatments. J Pain Symptom Manag 2007, 33(4):410-19.
24. Gadsby JG, Franks A, Jarvis P, Dewhurst F. Acupuncture-like transcutaneous electrical nerve stimulation within palliative care. Complement Ther Med 1997, 5:13-18.
25. Robb KA, Bennett MI, Johnson MI, Simpson KJ, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev 2008, (3). CD006276. DOI: 10.1002/14651858.CD006276.pub2
26. Occupational Therapy Intervention in Cancer: Guidance for Professionals, Managers and Decision Makers 2004, College of Occupational Therapists, HOPE the Specialist Section of Occupational Therapists in HIV/AIDs, Oncology, Palliative Care, Education, London, COT
27. Strong J, Bennett S. Cancer pain. Pain. A Textbook for Therapists 2002, Strong J, Unruh AWright ABaxter G. eds., Edinburgh, Churchill Livingstone
28. Staats P, Yearwood T, Wallace MS. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS. JAMA 2004, 291:63-70.
29. Cousins MJ, Bridenbaugh PO. Neural Blockade in Clinical Anesthesia and Management 1998, 3rd, edition, New York, Lippincott-Raven
30. McCarberg BH. The treatment of breakthrough pain. Pain Med 2007, 8(1):S8-13.
31. Vranken JH, Zuurmond WW, de Lange JJ. Continuous brachial plexus block as treatment for the Pancoast syndrome. Clin J Pain 2000, 16(4):327-33.
32. Cooper MG, Keneally JP, Kinchington D. Continuous brachial plexus neural blockade in a child with intractable cancer pain. J Pain Symptom Manag 1994, 9(4):277-81.
33. Amesbury B, O'Riordan J. The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer. Palliat Med 1999, 13(2):153-8.
34. Wong FCS, Lee TW, Yuen KK. Intercostal nerve blockade for cancer pain: Effectiveness and selection of patients. Hong Kong Med J 2007, 13:266-70.
35. Doyle D. Nerve blocks in advanced cancer. Practitioner 1982, 226(1365):541-4.
36. Eisenberg E, Carr DB, Chalmers CT. Neurolytic coeliac plexus block for treatment of cancer pain a meta-analysis. Anesth Analg 1995, 80:290-5.
37. Weber J, Brown D, Stephens D, Wong G. Celiac plexus block: Retrocrural computed tomographic anatomy in patients with and without pancreatic cancer. Region Anesth 1996, 5:407-13.
38. Lieberman R, Nance P, Cuka D. Anterior approach to celiac plexus block during interventional biliary procedures. Radiology 1988, 167:562-4.
39. Abeldi M, Zfass A. Endoscopic ultrasound-guided neurolytic celiac plexus block. J Clin Gastroenterol 2001, 32:390-3.
40. Ina H, Kitoh T, Kobayashi M. New technique for the neurolytic celiac plexus block: The transintervertebral disc approach. Anesthesiology 1996, 85:212-17.
41. Haaga JR, Kori SH, Eastwood DW, Borkowski GP. Improved technique for CT-guided celiac ganglia block. Am J Roentgenol 1984, 142:1201-4.
42. Hol P, Kvarstein G, Viken O, Smedby O, Tonnessen T. MRI-guided celiac plexus block. J Magn Reson Imag 2000, 12:562-4.
43. Akhan O, Altinok D, Özmen MN, Oguzkurt L, Besim A. Correlation between the grade of tumoral invasion and pain relief in patients with celiac ganglia block. Am J Roentgenol 1997, 168:1565-7.
44. DeCicco M, Matovic M, Bortolussi R. Celiac plexus block: Injectate spread and pain relief in patients with regional anatomic distortions. Anesthesiology 2001, 94:561-5.
45. Perello A, Ashford NS, Dolin SJ. Coeliac plexus block using computed tomography guidance. Palliative Med 1999, 13(5):419-25.
46. Wong GY, Schroeder DR, Carns PE. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: A randomized controlled trial. JAMA 2004, 291:1092-9.
47. Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic. Cancer Am J Gastroenterol 2007, 102(2):430-8.
48. Fugere F, Lewis G. Coeliac plexus block for chronic pain syndromes. Can J Anaesth 1993, 40:954-63.
49. Hastings R, McKay W. Treatment of benign chronic abdominal pain with neurolytic celiac plexus block. Anesthesiology 1991, 75:156-8.
50. Davies DD. Incidence of major complications of neurolytic celiac plexus block. J Roy Soc Med 1993, 86:264-6.
51. Raj PP, Sahinler B, Lowe M. Radiofrequency lesioning of splanchnic nerves. Pain Pract 2002, 2(3):241-7.
52. Plancarte R, de Leon-Casasola OA, El-Helaly M, Allende S, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth 1997, 22:562-8.
53. Kanazi GE, Perkins FM, Thakur R, Dotson E. New technique for superior hypogastric plexus block. Region Anesth Pain Med 1999, 24(5):473-6.
54. Rabah E, Souyet H, Aguilera C, Neurolytic Elzo JJ. Block of the ganglion impar (walther) chronic radiation proctitis. Analgesia 2001, 5(2):63-5.
55. Lynch J, Zech D, Grond S. The role of intrathecal neurolysis in the treatment of cancer-related perianal and perineal pain. Palliat Med 1992, 6(2):140-5.
56. Baker L, Lee M, Regnard C, Crack L, Callin S. Evolving spinal analgesia practice in palliative care. Palliat Med 2004, 18:507-15.
57. Williams JE, Louw G, Towlerton G. Intrathecal pumps for giving opioids in chronic pain: A systematic review. Health Technol Assess 2000, 4(32):1-65.
58. Mueller-Schwefe G, Hassenbusch SJ, Reig E. Cost effectiveness of intrathecal therapy for pain. Neuromodulation 1999, 2(2):77-87.
59. Smith TJ, Staats PS, Deer T. Implantable drug delivery systems study group. Randomised clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain; impact on pain, drug related toxicity and survival. J Clin Oncol 2002, 20:4040-9.
60. Smith TJ, Coyne PJ, Staats PS. An implantable drug delivery system (IDSS) for refractory cancer pain provides sustained pain control, less drug related toxicity and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 2005, 16:825-33.
61. Intrathecal Drug Delivery for the Management of Pain and Spasticity in Adults; Recommendations for Best Clinical Practice 2008, The British Pain Society, London, The British Pain Society
62. Van Dongen RTM, Crul BJP, Van Egmond J. Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 1999, 15(3):166-72.
63. Eisenach JC, De Kock M, Klimscha W. Alpha sub 2-Adrenergic Agonists for Regional Anesthesia: A Clinical Review of Clonidine (1984-1995). Anesthesiology 1996, 85:655-74.
64. Higginson I, Astin P, Dolan S. Where do cancer patients die? Ten year trends in the place of death of cancer patients in England. Palliative Med 1998, 12(5):353-63.
65. Gestin Y, Vainio A, Pegurier A. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesth Scand 1997, 41(1):12-17.
66. Crul BJ, Delhaas EM. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: A review of 140 cases. Region Anesth Pain Med 1991, 16(4):209-13.
67. Nitescu P, Applegren L, Lindler L. Epidural versus intrathecal morphine bupivacaine: Assessment of consecutive treatments in advanced cancer pain. J Pain Symptom Manag 1990, 5:18-26.
68. Mercadante S. Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. J Pain Symptom Manag 1994, 9(3):201-7.
69. Control of Pain in Patients with Cancer 2000, Scottish Intercollegiate Guidelines Network (SIGN 44), Edinburgh, NHS Quality Improvement Scotland
70. Jackson MB, Pounder D, Price C, Matthews AW, Neville E. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax 1999, 54:238-41.
71. Crul BJP, Blok LM, Van Egmond J, Van Dongen RTM. The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headache Pain 2005, 6(1):24-9.
72. Jones B, Finlay I, Ray A, Simpson B. Is there still a role for open cordotomy in cancer pain management? J Pain Symptom Manag 2003, 25:179-84.
73. Gildenberg PL. Myelotomy through the years. Stereot Funct Neuros 1991, 77:169-71.
74. Hirschberg RM, Al-Chaer ED, Lawand NB, Westlund KN, Willis WD. Is there a pathway in the posterior funiculus that signals visceral pain? Pain 1996, 67(2-3):291-305.
75. Nauta HJ, Soukup VM, Fabian RH. Punctate midline myelotomy for the relief of visceral cancer pain. J Neurosurg 2000, 92(2):125-30. suppl
76. Gangi A, Dietemann JL, Guth S, Steib JP, Roy C. Computed tomography and fluoroscopy-guided vertebroplasty: Results and complications in 187 patients. Semin Intervent Rad 1999, 16(2):137-41.
77. Fourney DR, Schomer DF, Nader R. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003, 98(1):21-30.
78. Dudeney S, Lieberman IH, Reinhardt MK, Hussein M. Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol 2002, 20(9):2382-7.
79. Hentschel SJ, Burton AW, Fourney DR, Rhines LD, Mendel E. Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: Refuting proposed contraindications. J Neurosurg-Spine 2005, 2(4):436-40.
80. Ernst E, Pittler MH, Wider B, Boddy K. Complementary Therapies for Pain Management 2007, London, Elsevier/Mosby
81. Goldstein MS, Brown ER, Ballard-Barbash R. The use of complementary and alternative medicine among Californian adults with and without cancer. Evid-Based Compl Alt 2005, 2:557-65.
82. Ernst E, Pittler MH, Wider B, Boddy K. Oxford Handbook of Complementary Medicine 2008, Oxford, Oxford University Press
83. Lee H, Schmidt K, Ernst E. Acupuncture for the relief of cancer-related pain-A systematic review. Eur J Pain 2005, 9:437-41.
84. Ernst E, Pittler M, Wider B, Boddy K. The Desktop Guide to Complementary and Alternative Medicine 2006, 2nd, edition, London, Elsevier/Mosby
85. Fellowes D, Barnes K, Wilkinson S. Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Database Syst Rev 2004, (3). CD002287
86. Milazzo S, Russell N, Ernst E. Efficacy of homeopathic therapy in cancer treatment. Eur J Cancer 2006, 42:282-9.
87. Rajasekaran M, Edmonds PM, Higginson IL. Systematic review of hypnotherapy for treating symptoms in terminally ill adult cancer patients. Palliative Med 2005, 19:418-26.
88. Wild MR, Espie C. The efficacy of hypnosis in the reduction of procedural pain and distress in pediatric oncology: A systematic review. J Dev Behav Pediatr 2004, 25:207-13.
89. Richardson J, Smith JE, McCall G, Pilkington K. Hypnosis for procedure-related pain and distress in pediatric cancer patients: A systematic review of effectiveness and methodology related to hypnosis interventions. J Pain Symptom Manag 2006, 31:70-84.
90. Corbin L. Safety and efficacy of massage therapy for patients with cancer. Cancer Control 2005, 12(3):158-64.
91. Stephenson NL, Weinrich SP, Tavakoli AS. The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum 2000, 27:67-72.
92. Campbell FA, Tramer MR, Carroll D. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. Br Med J 2001, 323:13-16.
93. Perkins P, Booth S, Vowler SL, Barclay S. What are patients' priorities for palliative care research? A questionnaire study. Palliative Med 2008, 22(1):7-12.
94. Hearn J, Higginson IJ. Epidemiology of cancer pain: A systematic review. Cancer Pain 2003, Portenoy RK, Bruera E. eds., New York, Cambridge University Press
95. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007, 18(9):1437-49.
96. Breivik H, Cherny N, Collett B. Cancer-related pain: A pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009, 20(8):1420-33.
97. Klepstad P, Loge JH, Borchgrevink PC. The Norwegian Brief Pain Inventory Questionnaire: Translation and validation in cancer pain patients. J Pain Symptom Manag 2002, 24(5):517-25.
98. Yates PM, Edwards HE, Nash RE. Barriers to effective cancer pain management: A survey of hospitalised cancer patients in Australia. J Pain Symptom Manag 2002, 23(5):393-405.
99. Cleary JF, Carbone PP. Palliative medicine in the elderly. Cancer 1997, 80(1):1335-47.
100. Mercadante S, Arcuri E. Pharmacological management of cancer pain in the elderly. Drug Aging 2007, 24(9):761-76.
101. Delgado-Guay MO, Bruera E. Management of pain in the older person with cancer. Oncology 2008, 22(1):56-61.
102. Viganó A, Bruera E, Suarez-Almazor ME. Age, pain intensity and opioid dose in patients with advanced cancer. Cancer 1998, 83(6):1244-50.
103. Mercadante S, Ferrera P, Villari P, Casuccio A. Opioid escalation in patients with cancer pain: The effect of age. J Pain Symptom Manag 2006, 32(5):413-19.
104. Mercadante S, Roila F, Berretto O, Labianca R, Casilini S. DOMAIN-AIOM study group. Prevalence and treatment of cancer pain in Italian oncological wards centres: A cross-sectional survey. Support Care Cancer 2008, 16(11):1203-11.
105. Bennett MI, Closs SJ, Chatwin J. Cancer pain management at home (I): Do older patients experience less effective management than younger patients? Support Care Cancer 2009, 17(7):787-92.
106. Allen RS, Haley WE, Small BJ, McMillan SC. Pain reports by older hospice cancer patients and family caregivers: The role of cognitive functioning. Gerontologist 2002, 42(4):507-14.
107. Cleeland C, Gonin R, Hatfield A. Pain and its treatment in outpatients with metastatic cancer. New Engl J Med 1994, 330(9):592-6.
108. Bernabei R, Gambassi G, Lapane K. Management of pain in elderly patients with cancer. JAMA 1998, 279(23):1877-82.
109. Hall S, Gallagher RM, Gracely E, Knowlton C, Weschules D. The terminal cancer patient: Effects of age, gender and primary tumour site on opioid dose. Pain Med 2003, 4(2):125-34.
110. Loick G, Radbruch L, Sabatowski R. Morphine dose and side effects: A comparison of older and younger patients with tumor pain. Dtsch Med Wochenschr 2000, 125(41):1216-21.
111. Yeager KA, Miaskowski C, Dibble S, Wallhagan M. Differences in pain knowledge in cancer patients with and without pain. Cancer Pract 1997, 5(1):39-45.
112. Closs SJ, Chatwin J, Bennett MI. Cancer pain management at home (II): Does age influence attitudes towards pain and analgesia? Support Care Cancer 2009, 17(7):781-6.
113. Higginson IJ, Costantini M, Boni L. Effect of a palliative home care team on hospital admissions among patients with advanced cancer. Palliative Med 2003, 17(4):315-21.
114. Jordhøy M, Fayers P, Saltnes T. A palliative-care intervention and death at home: A cluster randomised trial. Lancet 2000, 356(9233):888-93.
115. Ward S, Goldberg N, Miller-McCauley V, Mueller C, Nolan A. Patient related barriers to management of cancer pain. Pain 1993, 52:319-24.
116. Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S. Patient related barriers to pain management: The barriers questionnaire II(BQ-II). Pain 2002, 99:385-96.
117. Bosch F, Baños JE. Religious beliefs of patients and caregivers as a barrier to the pharmacological control of cancer pain. Clin Pharmacol Ther 2002, 72(2):107-11.
118. Peacock S, Patel S. Cultural influences on pain. RIP Br Pain Soc 2008, 1(2):6-9.
119. Lin CC. Barriers to the analgesic management of cancer pain: A comparison of attitudes of Taiwanese patients and their family caregivers. Pain 2000, 88:7-14.
120. Letizia M, Creech S, Norton E, Shanahan M, Hedges L. Barriers to caregiver administration of pain medication in hospice care. J Pain Symptom Manag 2004, 27(2):114-24.
121. Furstenberg CT, Ahles TA, Whedon MB. Knowledge and attitudes of health-care providers toward cancer pain management: A comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manag 1998, 15(6):335-49.
122. Xue Y, Schulman-Green D, Czaplinski C, Harris D, McCorkle R. Pain attitudes and knowledge among RNs, pharmacists, and physicians on an inpatient oncology service. Clin J Oncol Nurs 2007, 11(5):687-95.
123. Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. " We don't carry that" -Failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 2000, 342(14):1023-6.
124. Green CR, Ndao-Brumblay SK, West B, Washington T. Differences in prescription opioid analgesic availability: Comparing minority and white pharmacies across Michigan. J Pain 2005, 6(10):689-99.
125. Bennett MI, Bagnall AM, Closs SJ. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain 2009, 143(3):192-9.
126. Caraceni A, Zecca E, Bonezzi C. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004, 22(14):2909-17.
127. Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: A randomized, double-blind, placebo controlled cross-over trial. J Clin Oncol 2004, 22(16):3389-94.
128. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: A new frontier. Pain Med 2007, 8:189-98.
129. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006, 33:15-49.
130. Flatters SJ, Bennett GJ. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 2006, 122:245-57.
131. Cata JP, Weng HR, Lee BN, Reuben JM, Dougherty PM. Clinical and experimental findings in humans and animals with chemotherapy induced peripheral neuropathy. Minerva Anestesiol 2006, 72:151-69.
132. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002, 249:9-17.
133. Cersosimo RJ. Oxaliplatin-associated neuropathy: A review. Ann Pharmacother 2005, 39:128-35.
134. Verstappen CC, Postma TJ, Hoekman K, Heimans JJ. Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer. J Neurooncol 2003, 63:201-5.
135. Richardson PG, Briemberg H, Jagannath S. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol 2006, 24(19):3113-20.
136. Argyriou AA, Chroni E, Koutras A. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial. Neurology 2005, 64:26-31.
137. Argyriou AA, Chroni E, Koutras A. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: Final results. Support Care Cancer 2006, 14:1134-40.
138. Xiao W, Boroujerdi A, Bennett GJ, Luo ZD. Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 2007, 144:714-20.
139. Wong GY, Michalak JC, Sloan JA, Lorprinzi CL. A phase III, double blinded, placebo controlled randomised trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy. A North Central Cancer Group Study. J Clin Oncol 2005, 23(16). Abstract 8001
140. Attal N, Cruccu G, Haanpaa M. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006, 13:1153-69.
141. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005, 118:289-305.
142. Dworkin RH, O'Connor AB, Backonja M. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007, 132(3):237-51.
143. Barranger E, Dubernard G, Fleurence J. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 2005, 92:17-22.
144. Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 1995, 6:453-9.
145. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. Regional block and mexiletine: The effect on pain after cancer breast surgery. Region Anesth Pain M 2001, 26:223-8.
146. Maguire MF, Ravenscroft A, Beggs D, Duffy JP. A questionnaire study investigating the prevalence of the neuropathic component of chronic pain after thoracic surgery. Eur J Cardiothorac Surg 2006, 29:800-5.
147. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000, 93:1123-33.
148. van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, Roodenburg JL. Morbidity of the neck after head and neck cancer therapy. Head Neck 2004, 26:785-91.
149. Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, Michalska T, Zalucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-A review. Acta Oncol 2006, 45:280-4.
150. Olsen NK, Pfeiffer P, Johannsen L, Schroder H, Rose C. Radiation induced brachial plexopathy: Neurological follow-up in 161 recurrence free breast cancer patients. Int J Radiat Oncol 1993, 26:43-9.
151. Fathers E, Thrush D, Huson SM, Norman A. Radiation-induced brachial plexopathy in women treated for carcinoma of the breast. Clin Rehabil 2002, 16:160-5.
152. Bye A, Trope C, Loge JH, Hjermstad M, Kaasa S. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy-evaluation of long-term effects of diagnosis and treatment. Acta Oncol 2000, 39:173-80.
153. William L, Macleod R. Management of breakthrough pain in cancer patients. Drugs 2008, 68(7):913-24.
154. Trotti A, Bellm LA, Epstein JB. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003, 66:253-62.
155. Clarkson JE, Worthington HV, Eden TOB. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2007, (1). CD001973. DOI: 10.1002/14651858. CD001973.pub3
156. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004, 4(4):277-84.
157. The management of persistent pain in older persons. J Am Geriatr Soc 2002, 50:S205-24. American Geriatric Society Panel on Persistent Pain in Older Persons
158. McCulloch R, Comac M, Craig F. Paediatric palliative care: coming of age in oncology. Eur J Cancer 2008, 44(8):1139-45.
159. Wolfe J, Grier HE, Klar N. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000, 342(5):326-33.
160. Liossi C, Schoth DE, Bradley BP, Mogg K. The time course of attentional bias for pain-related cues in chronic daily headache suffers. Eur J Pain 2008, 13(9):963-9.
161. Commissioning Children and Young People's Palliative Care Services: A Practical Guide for the NHS Commissioners 2005, Department of Health, London, Department of Health